- Home
- EWTX vs BYD Comparison
EWTX vs BYD Comparison
Compare EWTX & BYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EWTX | BYD |
|---|---|---|
| Founded | 2017 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.8B |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | EWTX | BYD |
|---|---|---|
| Price | $39.14 | $69.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 19 |
| Target Price | $52.62 | ★ $95.50 |
| AVG Volume (30 Days) | ★ 1.4M | 1.0M |
| Earning Date | 11-05-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 1.14% |
| EPS Growth | N/A | ★ 264.46 |
| EPS | N/A | ★ 3.12 |
| Revenue | N/A | ★ $2,626,730,000.00 |
| Revenue This Year | N/A | $0.15 |
| Revenue Next Year | N/A | $2.19 |
| P/E Ratio | ★ N/A | $22.44 |
| Revenue Growth | N/A | ★ 9.41 |
| 52 Week Low | $14.25 | $65.00 |
| 52 Week High | $48.51 | $91.41 |
Technical Indicators
Market Signals| Indicator | EWTX | BYD |
|---|---|---|
| Relative Strength Index (RSI) | 39.09 | 36.31 |
| Support Level | $37.75 | $65.00 |
| Resistance Level | $41.04 | $90.05 |
| Average True Range (ATR) | 1.95 | 1.78 |
| MACD | -0.25 | 0.38 |
| Stochastic Oscillator | 22.30 | 44.21 |
Price Performance
Historical ComparisonAbout EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.
About BYD Boyd Gaming Corporation
Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. The Midwest and South hold the key number of entertainment properties and generate the majority of the company's revenue.